Skip to main content
Home
  • About
    About
    • Our story
    • Our leaders
    Connect
    • Send a Message
    • Our Offices
  • Solutions
    Solutions
    • Life Sciences Commercialization
    • Value & Access
    • Strategic Consulting
    • Envision Medical Communications
    • JAPAC ProScribe is the most internationally recognized and regionally respected medical communication company in the Asian-Pacific region.
    Connect
    • Send a Message
    • Our Offices
  • Technology
    Technology
    • Technologies Industry-leading technology-enabled strategic solutions
    • EnvisionOne New, superior-in-class SaaS platform to elevate and synchronize medical information, medical communications, and improve outcomes
    • iEnvision Medical affairs workflow platform
    • EnvisionOne Vantage Benchmarking software to optimize publication strategies through data-driven insights
    • EnvisionOne Insights A unified data & analytics solution for medical affairs
    • OKRA.ai Artificial intelligence built for life sciences
    Connect
    • Send a Message
    • Our Offices
  • News & Events
  • Careers
    Careers
    • Life at Envision
    • Benefits at Envision
    • Open Opportunities
    • Login
    • Join our Talent Community
    • FAQs
    Connect
    • Send a Message
    • Our Offices
  • social
    Connect
    • Send a Message
    • Our Offices
Connect
  • Send a Message
  • Our Offices
  • Connect
    Connect
    • Send a Message
    • Our Offices

Our Leaders

Alistair Macdonald

Alistair Macdonald

Executive Chairman
Ellipse 71

Paul Archer

Chief Commercial Strategy Officer
Ben Rudnick

Ben Rudnick

Chief Financial Officer
Alice-Choi

Alice Choi

President, Envision Medical Communications (EMC)
Ellipse 69

Adam Deutsch

General Counsel
Ellipse 72

Rich Gorman

President, Strategic Consulting
Bill Shirey

Bill Shirey

President, Life Sciences Commercialization
Ellipse 67

Jim Streeter

President of Technology, Chief Technology Officer
Home

Terms of use  Privacy Notice  Cookies Notice  ISO/IEC 27001 Certified

Footer
  • Sustainability Report
  • Envision's Policies

© 2001-2024 Envision Pharma Group.  All rights reserved.